BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 7845667)

  • 61. Biology of EWS/FLI and related fusion genes in Ewing's sarcoma and primitive neuroectodermal tumor.
    May WA; Denny CT
    Curr Top Microbiol Immunol; 1997; 220():143-50. PubMed ID: 9103680
    [No Abstract]   [Full Text] [Related]  

  • 62. Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2and c-Myc expression.
    Dauphinot L; De Oliveira C; Melot T; Sevenet N; Thomas V; Weissman BE; Delattre O
    Oncogene; 2001 May; 20(25):3258-65. PubMed ID: 11423975
    [TBL] [Abstract][Full Text] [Related]  

  • 63. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma.
    Kinsey M; Smith R; Lessnick SL
    Mol Cancer Res; 2006 Nov; 4(11):851-9. PubMed ID: 17114343
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Identification of Ewing's sarcoma protein as a G-quadruplex DNA- and RNA-binding protein.
    Takahama K; Kino K; Arai S; Kurokawa R; Oyoshi T
    FEBS J; 2011 Apr; 278(6):988-98. PubMed ID: 21244633
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differential regulation of the response to DNA damage in Ewing's sarcoma cells by ETS1 and EWS/FLI-1.
    Soldatenkov VA; Trofimova IN; Rouzaut A; McDermott F; Dritschilo A; Notario V
    Oncogene; 2002 Apr; 21(18):2890-5. PubMed ID: 11973649
    [TBL] [Abstract][Full Text] [Related]  

  • 66. EWS/FLI and its downstream target NR0B1 interact directly to modulate transcription and oncogenesis in Ewing's sarcoma.
    Kinsey M; Smith R; Iyer AK; McCabe ER; Lessnick SL
    Cancer Res; 2009 Dec; 69(23):9047-55. PubMed ID: 19920188
    [TBL] [Abstract][Full Text] [Related]  

  • 67. EWS-FLI1 fusion transcripts identified in patients with typical neuroblastoma.
    Burchill SA; Wheeldon J; Cullinane C; Lewis IJ
    Eur J Cancer; 1997 Feb; 33(2):239-43. PubMed ID: 9135495
    [TBL] [Abstract][Full Text] [Related]  

  • 68. EWS/FLI mediates transcriptional repression via NKX2.2 during oncogenic transformation in Ewing's sarcoma.
    Owen LA; Kowalewski AA; Lessnick SL
    PLoS One; 2008 Apr; 3(4):e1965. PubMed ID: 18414662
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities.
    Mao X; Miesfeldt S; Yang H; Leiden JM; Thompson CB
    J Biol Chem; 1994 Jul; 269(27):18216-22. PubMed ID: 7517940
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Biology of Ewing sarcoma.
    Riggi N; Stamenkovic I
    Cancer Lett; 2007 Aug; 254(1):1-10. PubMed ID: 17250957
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP.
    Zinszner H; Albalat R; Ron D
    Genes Dev; 1994 Nov; 8(21):2513-26. PubMed ID: 7958914
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Interference with the constitutive activation of ERK1 and ERK2 impairs EWS/FLI-1-dependent transformation.
    Silvany RE; Eliazer S; Wolff NC; Ilaria RL
    Oncogene; 2000 Sep; 19(39):4523-30. PubMed ID: 11002425
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cryptic exons as a source of increased diversity of Ewing tumor-associated EWS-FLI1 chimeric products.
    Kovar H; Jugovic D; Melot T; Zoubek A; Lenoir G; Fink FM; Philip I; Turc-Carel C; Thomas G; Zucman-Rossi J
    Genomics; 1999 Sep; 60(3):371-4. PubMed ID: 10493837
    [TBL] [Abstract][Full Text] [Related]  

  • 74. DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma.
    Bailly RA; Bosselut R; Zucman J; Cormier F; Delattre O; Roussel M; Thomas G; Ghysdael J
    Mol Cell Biol; 1994 May; 14(5):3230-41. PubMed ID: 8164678
    [TBL] [Abstract][Full Text] [Related]  

  • 75. In situ reverse-transcriptase polymerase chain reaction demonstration of the EWS/FLI-1 fusion transcript in Ewing's sarcomas and peripheral primitive neuroectodermal tumors.
    Krams M; Peters J; Boeckel F; Raether A; Ambros PF; Parwaresch R; Harms D
    Virchows Arch; 2000 Sep; 437(3):234-40. PubMed ID: 11037342
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cooperative DNA binding with AP-1 proteins is required for transformation by EWS-Ets fusion proteins.
    Kim S; Denny CT; Wisdom R
    Mol Cell Biol; 2006 Apr; 26(7):2467-78. PubMed ID: 16537893
    [TBL] [Abstract][Full Text] [Related]  

  • 77. EWS/ETS proteins promote expression and regulate function of the homeodomain transcription factor BRN3A.
    Gascoyne DM; Dunne J; Behjati S; Sebire NJ; Anderson J; Latchman DS
    Oncogene; 2010 May; 29(21):3134-45. PubMed ID: 20348952
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An EWS/ERG fusion with a truncated N-terminal domain of EWS in a Ewing's tumor.
    Peter M; Mugneret F; Aurias A; Thomas G; Magdelenat H; Delattre O
    Int J Cancer; 1996 Jul; 67(3):339-42. PubMed ID: 8707406
    [TBL] [Abstract][Full Text] [Related]  

  • 79. EWS/FLI alters 5'-splice site selection.
    Knoop LL; Baker SJ
    J Biol Chem; 2001 Jun; 276(25):22317-22. PubMed ID: 11301318
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Ews/Fli-1 fusion gene changes the status of p53 in neuroblastoma tumor cell lines.
    Rorie CJ; Weissman BE
    Cancer Res; 2004 Oct; 64(20):7288-95. PubMed ID: 15492248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.